{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:14:06Z","timestamp":1792088046219,"version":"4.4.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,6,23]],"date-time":"2014-06-23T00:00:00Z","timestamp":1403481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,6,23]],"date-time":"2014-06-23T00:00:00Z","timestamp":1403481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/ncomms5177","type":"journal-article","created":{"date-parts":[[2014,6,23]],"date-time":"2014-06-23T10:34:30Z","timestamp":1403519670000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":162,"title":["Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation"],"prefix":"10.1038","volume":"5","author":[{"given":"Goro","family":"Sashida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiko","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Yui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Mochizuki-Kashio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsunori","family":"Saraya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Koseki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Iwama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,23]]},"reference":[{"key":"BFncomms5177_CR1","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","volume":"364","author":"R Bejar","year":"2011","unstructured":"Bejar, R. et al. Clinical effect of point mutations in myelodysplastic syndromes. N. Engl. J. Med. 364, 2496\u20132506 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFncomms5177_CR2","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nrc3343","volume":"12","author":"AH Shih","year":"2012","unstructured":"Shih, A. H., Abdel-Wahab, O., Patel, J. P. & Levine, R. L. The role of mutations in epigenetic regulators in myeloid malignancies. Nat. Rev. Cancer 12, 599\u2013612 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncomms5177_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s12185-012-1181-z","volume":"96","author":"YR Chung","year":"2012","unstructured":"Chung, Y. R., Schatoff, E. & Abdel-Wahab, O. Epigenetic alterations in hematopoietic malignancies. Int. J. Hematol. 96, 413\u2013427 (2012).","journal-title":"Int. J. Hematol."},{"key":"BFncomms5177_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s12185-012-1183-x","volume":"96","author":"G Sashida","year":"2012","unstructured":"Sashida, G. & Iwama, A. Epigenetic regulation of hematopoiesis. Int. J. Hematol. 96, 405\u2013412 (2012).","journal-title":"Int. J. Hematol."},{"key":"BFncomms5177_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.stem.2010.08.002","volume":"7","author":"M Sauvageau","year":"2010","unstructured":"Sauvageau, M. & Sauvageau, G. Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer. Cell Stem Cell 7, 299\u2013313 (2010).","journal-title":"Cell Stem Cell"},{"key":"BFncomms5177_CR6","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nature02985","volume":"431","author":"H Wang","year":"2004","unstructured":"Wang, H. et al. Role of histone H2A ubiquitination in Polycomb silencing. Nature 431, 873\u2013878 (2004).","journal-title":"Nature"},{"key":"BFncomms5177_CR7","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1126\/science.1076997","volume":"298","author":"R Cao","year":"2002","unstructured":"Cao, R. et al. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298, 1039\u20131043 (2002).","journal-title":"Science"},{"key":"BFncomms5177_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nature04733","volume":"441","author":"La Boyer","year":"2006","unstructured":"Boyer, L. a. et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441, 349\u2013353 (2006).","journal-title":"Nature"},{"key":"BFncomms5177_CR9","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1126\/science.1100576","volume":"306","author":"NJ Francis","year":"2004","unstructured":"Francis, N. J., Kingston, R. E. & Woodcock, C. L. Chromatin compaction by a polycomb group protein complex. Science 306, 1574\u20131577 (2004).","journal-title":"Science"},{"key":"BFncomms5177_CR10","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.cell.2011.12.029","volume":"148","author":"L Tavares","year":"2012","unstructured":"Tavares, L. et al. RYBP-PRC1 complexes mediate H2A ubiquitylation at polycomb target sites independently of PRC2 and H3K27me3. Cell 148, 664\u2013678 (2012).","journal-title":"Cell"},{"key":"BFncomms5177_CR11","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.molcel.2013.02.013","volume":"49","author":"Ja Simon","year":"2013","unstructured":"Simon, J. a. & Kingston, R. E. Occupying chromatin: polycomb mechanisms for getting to genomic targets, stopping transcriptional traffic, and staying put. Mol. Cell 49, 808\u2013824 (2013).","journal-title":"Mol. Cell"},{"key":"BFncomms5177_CR12","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.molcel.2011.11.032","volume":"45","author":"M Yu","year":"2012","unstructured":"Yu, M. et al. Direct recruitment of Polycomb repressive complex 1 to chromatin by core binding transcription factors. Mol. Cell 45, 330\u2013343 (2012).","journal-title":"Mol. Cell"},{"key":"BFncomms5177_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/ng.518","volume":"42","author":"RD Morin","year":"2010","unstructured":"Morin, R. D. et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat. Genet. 42, 181\u2013185 (2010).","journal-title":"Nat. Genet."},{"key":"BFncomms5177_CR14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/ncomms1623","volume":"3","author":"A Herrera-Merchan","year":"2012","unstructured":"Herrera-Merchan, A. et al. Ectopic expression of the histone methyltransferase Ezh2 in haematopoietic stem cells causes myeloproliferative disease. Nat. Commun. 3, 623 (2012).","journal-title":"Nat. Commun."},{"key":"BFncomms5177_CR15","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1182\/blood-2011-11-394932","volume":"120","author":"S Tanaka","year":"2012","unstructured":"Tanaka, S. et al. Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia. Blood 120, 1107\u20131117 (2012).","journal-title":"Blood"},{"key":"BFncomms5177_CR16","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ng.621","volume":"42","author":"T Ernst","year":"2010","unstructured":"Ernst, T. et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat. Genet. 42, 722\u2013726 (2010).","journal-title":"Nat. Genet."},{"key":"BFncomms5177_CR17","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/ng.620","volume":"42","author":"G Nikoloski","year":"2010","unstructured":"Nikoloski, G. et al. Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes. Nat. Genet. 42, 665\u2013667 (2010).","journal-title":"Nat. Genet."},{"key":"BFncomms5177_CR18","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1200\/JCO.2011.40.7379","volume":"30","author":"R Bejar","year":"2012","unstructured":"Bejar, R. et al. Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes. J. Clin. Oncol. 30, 3376\u20133382 (2012).","journal-title":"J. Clin. Oncol."},{"key":"BFncomms5177_CR19","doi-asserted-by":"publisher","first-page":"6109","DOI":"10.1182\/blood-2011-12-397620","volume":"119","author":"A Jerez","year":"2012","unstructured":"Jerez, A. et al. Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis. Blood 119, 6109\u20136117 (2012).","journal-title":"Blood"},{"key":"BFncomms5177_CR20","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1084\/jem.20131144","volume":"210","author":"T Muto","year":"2013","unstructured":"Muto, T. et al. Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders. J. Exp. Med. 210, 2627\u20132639 (2013).","journal-title":"J. Exp. Med."},{"key":"BFncomms5177_CR21","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/sj.leu.2404136","volume":"20","author":"H Niimi","year":"2006","unstructured":"Niimi, H. et al. Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1\/RUNX1 point mutations. Leukemia. 20, 635\u2013644 (2006).","journal-title":"Leukemia."},{"key":"BFncomms5177_CR22","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1182\/blood-2003-09-3074","volume":"103","author":"H Harada","year":"2004","unstructured":"Harada, H. et al. High incidence of somatic mutations in the AML1\/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia. Blood 103, 2316\u20132324 (2004).","journal-title":"Blood"},{"key":"BFncomms5177_CR23","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","volume":"122","author":"E Papaemmanuil","year":"2013","unstructured":"Papaemmanuil, E. et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 122, 3616\u20133627 (2013).","journal-title":"Blood"},{"key":"BFncomms5177_CR24","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1182\/blood-2007-01-068346","volume":"111","author":"N Watanabe-Okochi","year":"2008","unstructured":"Watanabe-Okochi, N. et al. AML1 mutations induced MDS and MDS\/AML in a mouse BMT model. Blood 111, 4297\u20134308 (2008).","journal-title":"Blood"},{"key":"BFncomms5177_CR25","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1182\/blood.V85.1.194.bloodjournal851194","volume":"85","author":"K Sawada","year":"1995","unstructured":"Sawada, K. et al. Proliferation and differentiation of myelodysplastic CD34+ cells: phenotypic subpopulations of marrow CD34+ cells. Blood 85, 194\u2013202 (1995).","journal-title":"Blood"},{"key":"BFncomms5177_CR26","doi-asserted-by":"publisher","first-page":"11842","DOI":"10.1073\/pnas.2034201100","volume":"100 (suppl.)","author":"E Passegu\u00e9","year":"2003","unstructured":"Passegu\u00e9, E., Jamieson, C. H. M., Ailles, L. E. & Weissman, I. L. Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc. Natl Acad. Sci. USA 100 (suppl.), 11842\u201311849 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms5177_CR27","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.cell.2007.05.014","volume":"129","author":"CR Walkley","year":"2007","unstructured":"Walkley, C. R. et al. A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency. Cell 129, 1097\u20131110 (2007).","journal-title":"Cell"},{"key":"BFncomms5177_CR28","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/nature08851","volume":"464","author":"MHGP Raaijmakers","year":"2010","unstructured":"Raaijmakers, M. H. G. P. et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 464, 852\u2013857 (2010).","journal-title":"Nature"},{"key":"BFncomms5177_CR29","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ccr.2012.02.018","volume":"21","author":"B Zhang","year":"2012","unstructured":"Zhang, B. et al. Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia. Cancer Cell 21, 577\u2013592 (2012).","journal-title":"Cancer Cell"},{"key":"BFncomms5177_CR30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.stem.2013.06.009","volume":"13","author":"K Schepers","year":"2013","unstructured":"Schepers, K. et al. Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche. Cell Stem Cell 13, 285\u2013299 (2013).","journal-title":"Cell Stem Cell"},{"key":"BFncomms5177_CR31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.cell.2005.02.029","volume":"121","author":"I Su","year":"2005","unstructured":"Su, I. et al. Polycomb group protein ezh2 controls actin polymerization and cell signaling. Cell 121, 425\u2013436 (2005).","journal-title":"Cell"},{"key":"BFncomms5177_CR32","doi-asserted-by":"publisher","first-page":"6553","DOI":"10.1182\/blood-2011-03-340554","volume":"118","author":"M Mochizuki-Kashio","year":"2011","unstructured":"Mochizuki-Kashio, M. et al. Dependency on the polycomb gene Ezh2 distinguishes fetal from adult hematopoietic stem cells. Blood 118, 6553\u20136561 (2011).","journal-title":"Blood"},{"key":"BFncomms5177_CR33","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1182\/blood.V100.1.238","volume":"100","author":"SC Kogan","year":"2002","unstructured":"Kogan, S. C. et al. Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood 100, 238\u2013245 (2002).","journal-title":"Blood"},{"key":"BFncomms5177_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1182\/asheducation-2008.1.43","volume":"2008","author":"SD Nimer","year":"2008","unstructured":"Nimer, S. D. MDS: a stem cell disorder--but what exactly is wrong with the primitive hematopoietic cells in this disease? Hematology. 2008, 43\u201351 (2008).","journal-title":"Hematology."},{"key":"BFncomms5177_CR35","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nrc3321","volume":"12","author":"A Raza","year":"2012","unstructured":"Raza, A. & Galili, N. The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes. Nat. Rev. Cancer 12, 849\u2013859 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncomms5177_CR36","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1084\/jem.20131141","volume":"210","author":"O Abdel-Wahab","year":"2013","unstructured":"Abdel-Wahab, O. et al. Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo. J. Exp. Med. 210, 2641\u20132659 (2013).","journal-title":"J. Exp. Med."},{"key":"BFncomms5177_CR37","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.molcel.2008.10.016","volume":"32","author":"X Shen","year":"2008","unstructured":"Shen, X. et al. EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. Mol. Cell 32, 491\u2013502 (2008).","journal-title":"Mol. Cell"},{"key":"BFncomms5177_CR38","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.stem.2007.10.003","volume":"1","author":"SM Chambers","year":"2007","unstructured":"Chambers, S. M. et al. Hematopoietic fingerprints: an expression database of stem cells and their progeny. Cell Stem Cell 1, 578\u2013591 (2007).","journal-title":"Cell Stem Cell"},{"key":"BFncomms5177_CR39","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s12185-010-0618-5","volume":"91","author":"S Goyama","year":"2010","unstructured":"Goyama, S. & Kurokawa, M. Evi-1 as a critical regulator of leukemic cells. Int. J. Hematol. 91, 753\u2013757 (2010).","journal-title":"Int. J. Hematol."},{"key":"BFncomms5177_CR40","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1056\/NEJMra023075","volume":"349","author":"JG Herman","year":"2003","unstructured":"Herman, J. G. & Baylin, S. B. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349, 2042\u20132054 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFncomms5177_CR41","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nature07815","volume":"458","author":"MaG Essers","year":"2009","unstructured":"Essers, M. a. G. et al. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 458, 904\u2013908 (2009).","journal-title":"Nature"},{"key":"BFncomms5177_CR42","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nri3062","volume":"11","author":"KY King","year":"2011","unstructured":"King, K. Y. & Goodell, M. a. Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat. Rev. Immunol. 11, 685\u2013692 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"BFncomms5177_CR43","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.1172\/JCI43873","volume":"120","author":"C Chen","year":"2010","unstructured":"Chen, C., Liu, Y., Liu, Y. & Zheng, P. Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice. J. Clin. Invest. 120, 4091\u20134101 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFncomms5177_CR44","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nature04980","volume":"442","author":"AV Krivtsov","year":"2006","unstructured":"Krivtsov, A. V. et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442, 818\u2013822 (2006).","journal-title":"Nature"},{"key":"BFncomms5177_CR45","doi-asserted-by":"publisher","first-page":"6628","DOI":"10.1158\/0008-5472.CAN-06-0458","volume":"66","author":"A Takeda","year":"2006","unstructured":"Takeda, A., Goolsby, C. & Yaseen, N. R. NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells. Cancer Res. 66, 6628\u20136637 (2006).","journal-title":"Cancer Res."},{"key":"BFncomms5177_CR46","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1182\/blood-2005-05-2003","volume":"106","author":"HJ Lawrence","year":"2005","unstructured":"Lawrence, H. J. et al. Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells. Blood 106, 3988\u20133994 (2005).","journal-title":"Blood"},{"key":"BFncomms5177_CR47","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1182\/blood-2012-06-434423","volume":"121","author":"Y Harada","year":"2013","unstructured":"Harada, Y. et al. RUNX1\/AML1 mutant collaborates with BMI1 overexpression in the development of human and murine myelodysplastic syndromes. Blood 121, 3434\u20133446 (2013).","journal-title":"Blood"},{"key":"BFncomms5177_CR48","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1182\/blood.V99.1.121","volume":"99","author":"U Thorsteinsdottir","year":"2002","unstructured":"Thorsteinsdottir, U. et al. Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood 99, 121\u2013129 (2002).","journal-title":"Blood"},{"key":"BFncomms5177_CR49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nm.2054","volume":"16","author":"DT Starczynowski","year":"2010","unstructured":"Starczynowski, D. T. et al. Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype. Nat. Med. 16, 49\u201358 (2010).","journal-title":"Nat. Med."},{"key":"BFncomms5177_CR50","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1053\/j.gastro.2007.06.016","volume":"133","author":"T Chiba","year":"2007","unstructured":"Chiba, T. et al. Enhanced self-renewal capability in hepatic stem\/progenitor cells drives cancer initiation. Gastroenterology 133, 937\u2013950 (2007).","journal-title":"Gastroenterology"},{"key":"BFncomms5177_CR51","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.exphem.2011.03.008","volume":"39","author":"T Konuma","year":"2011","unstructured":"Konuma, T. et al. Forced expression of the histone demethylase Fbxl10 maintains self-renewing hematopoietic stem cells. Exp. Hematol. 39, 697\u2013709 (2011).","journal-title":"Exp. Hematol."},{"key":"BFncomms5177_CR52","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/bioinformatics\/btr167","volume":"27","author":"F Krueger","year":"2011","unstructured":"Krueger, F. & Andrews, S. R. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics. 27, 1571\u20131572 (2011).","journal-title":"Bioinformatics."},{"key":"BFncomms5177_CR53","doi-asserted-by":"publisher","first-page":"R87","DOI":"10.1186\/gb-2012-13-10-r87","volume":"13","author":"A Akalin","year":"2012","unstructured":"Akalin, A. et al. methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles. Genome Biol. 13, R87 (2012).","journal-title":"Genome Biol."},{"key":"BFncomms5177_CR54","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/path.1539","volume":"202","author":"MRK Dasu","year":"2004","unstructured":"Dasu, M. R. K., Hawkins, H. K., Barrow, R. E., Xue, H. & Herndon, D. N. Gene expression profiles from hypertrophic scar fibroblasts before and after IL-6 stimulation. J. Pathol. 202, 476\u2013485 (2004).","journal-title":"J. Pathol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms5177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms5177","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms5177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T03:33:35Z","timestamp":1672976015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms5177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,23]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,9,22]]}},"alternative-id":["BFncomms5177"],"URL":"https:\/\/doi.org\/10.1038\/ncomms5177","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,23]]},"assertion":[{"value":"24 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4177"}}